Temozolomide in combination with fotemustine in patients with metastatic melanoma
CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.62, no.2, pp.293-298, 2008 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 62 Issue: 2
- Publication Date: 2008
- Doi Number: 10.1007/s00280-007-0606-5
- Journal Name: CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.293-298
- Istanbul University Affiliated: Yes
Abstract
Purpose Temozolomide and fotemustine are both active drugs for treating metastatic melanoma. The present study was designed to assess the efficacy and safety of combination therapy with temozolomide + fotemustine in patients with metastatic melanoma.